Update on colorectal cancer

American Family Physician

Volumn 61, Issue 6, 2000, Pages 1759-1770+1773

  Rudy, David R ^a   Zdon, Michael J ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMATOUS POLYP; CANCER LOCALIZATION; CANCER RISK; CANCER SCREENING; CANCER STAGING; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL PROTOCOL; COLON CARCINOMA; COLORECTAL CANCER; CROHN DISEASE; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; FAMILIAL CANCER; GENETIC ASSOCIATION; HUMAN; PROGNOSIS; RECTUM ADENOMA; REVIEW; ULCERATIVE COLITIS;

ALGORITHMS; COLONIC POLYPS; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; INFLAMMATORY BOWEL DISEASES; MASS SCREENING; NEOPLASM STAGING; PATIENT EDUCATION; POPULATION SURVEILLANCE; PRACTICE GUIDELINES; TEACHING MATERIALS; UNITED STATES;

EID: 0343570095     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. U.S. Preventive Services Task Force. Screening for colorectal cancer. In: Guide to clinical preventive services: report of the U.S. Preventive Services Task Force. 2d ed. Baltimore: Williams & Wilkins, 1996.
2. Screening for colorectal cancer⋯United States, 1997. MMWR Morb Mortal Wkly Rep 1999; 48:116-21.
3. Landis SH, Murry T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999;49:8-31.
4. Frame PS. A critical review of adult health maintenance. Part 3: prevention of cancer. J Fam Pract 1986;22:511-20.
5. Laken SJ, Petersen GM, Gruber SB, Oddoux C, Ostrer H, Giardiello FM, et al. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in ADC. Nat Genet 1997;17:79-83.
6. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997;112:594-642 [Published errata in Gastroenterology 1997;112:1060 and 1998;114: 635].
7. Chao A, Gilliland FD, Hunt WC, Bulterys M, Becker TM, Key CR. Increasing incidence of colon and rectal cancer among Hispanics and American Indians in New Mexico (United States), 1969-94. Cancer Causes Control 1998;9:137-44.
8. Kune S, Kune GA, Watson L. The Melbourne colorectal cancer study: incidence findings by age, sex, site, migrants and religion. Int J Epidemiol 1986;15:483-93.
9. Bat L, Pines A, Ron E, Niv Y, Arditi E, Shemesh E. A community-based program of colorectal cancer screening in an asymptomatic population: evaluation of screening tests and compliance. Am J Gastroenterol 1986;81:647-51.
10. Iskowitz SH, Kim YS. Colonic polyps and polyposis syndromes. In: Feldman M, Sleisenger MH, Scharschmidt BF, eds. Sleisinger & Fordtran's Gastrointestinal and liver disease; pathophysiology, diagnosis, management. 6th ed. Philadelphia: Saunders, 1998.
11. Launoy G, Smith TC, Duffy SW, Bouvier V. Colorectal cancer mass-screening: estimation of faecal occult blood test sensitivity, taking into account cancer mean sojourn time. Int J Cancer 1997; 73:220-4.
12. Burke W, Peterson G, Lynch P, Botkin J, Daly M, Garber J, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA 1997;277:915-9.
13. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997;336:1401-8.
14. Lynch HT, Shaw MW, Magnuson CW, Larsen AL, Krush AF. Hereditary factors in cancer. Study of two large midwestern kindreds. Arch Intern Med 1966;117:206-12.
15. Lynch HT, Smyrk TC. Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review. Cancer 1996;78:1149-67.
16. Stenson J. Hereditary form of colorectal cancer has better outlook. Medical Tribune FP Edition, June 19, 1997;38(12):29.
17. Vasen HF, Mecklin JP, Kahn PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424-5.
18. Bresalier RS, Kim YS. Malignant neoplasms of the large intestine. In: Feldman M, Sleisenger MH, Scharschmidt BF, eds. Sleisinger & Fordtran's Gastrointestinal and liver disease pathophysiology, diagnosis, management. 6th ed. Philadelphia: Saunders, 1998.
19. Guillem JG, Paty PB, Cohen AM. Surgical treatment of colorectal cancer. CA Cancer J Clin 1997; 47:113-28.
20. Mandel JS, Bond JH, Church JH, Snover DC, Bradley GM, Schuman LM, et al. Reducing morality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71 [Published erratum in N Engl J Med 1993;329:672].
21. Ederer F, Church TR, Mandel JS. Fecal occult blood screening in the Minnesota study: role of chance detection of lesions. J Natl Cancer Inst 1997;89: 1423-8.
22. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
23. Kronberg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
24. Jessup JM, Menck HR, Fremgen A, Winchester DP. Diagnosing colorectal carcinoma: clinical and molecular approaches. CA Cancer J Clin 1997;47:70-92.
25. Selby JV, Friedman GD, Quesenberry CB Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
26. Kewenter J, Brevinge H, Engaras B, Haglind E. The yield of flexible sigmoidoscopy and double-contrast barium enema in the diagnosis of neoplasms in the large bowel in patients with a positive Hemoccult test. Endoscopy 1995;27:159-63.
27. Lieberman DA. Cost-effectiveness model for colon cancer screening. Gastroenterology 1995;109: 1781-90.
28. Read TE, Kodner IJ. Colorectal cancer: risk factors and recommendations for early detection. Am Fam Physician 1999;59:3083-92.
29. Jewell DP. Ulcerative colitis. In: Feldman M, Sleisenger MH, Scharschmidt BF, eds. Sleisinger & Fordtran's gastrointestinal and liver disease; pathophysiology, diagnosis, management. 6th ed. Philadelphia: Saunders, 1998.
30. Thun MJ, Namboodiri BS, Heath CW Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991;325:1593-6.
31. Greenberg ER, Baron JA, Freeman DH Jr, Mandel JS, Haile R. Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group. J Natl Cancer Inst 1993;85:912-6.